Bio

Dormer Stephen is co-chair of the firm's Business and Finance Practice Group. He focuses his practice on advising emerging growth companies and investors in the life sciences, technology, financial services and manufacturing industries. Working closely with founders, CEOs, boards of directors and investors, Dormer counsels clients in a broad range of matters, from formation and spinoff transactions, to financings, governance, mergers, acquisitions and joint ventures, strategic collaborations, and technology acquisition and licensing matters. In the life sciences sector alone, Dormer has worked with hundreds of biotechnology companies whose research activities, products and services include biopharmaceuticals, diagnostics, drug delivery, genomics, healthcare informatics, medical devices, nanotechnology, pharmaceuticals, therapeutics and vaccines. A number of these businesses are spinoffs from research initiatives at Yale University, where he has also served for several years as a panel moderator at the annual Yale Innovation Summit.